I got dangerously sick while waiting for double-lung and liver transplants. But then I got a second chance at life after starting Trikafta, even though I have two rare mutations.

There are hundreds of publicly traded companies on various equity markets worldwide. Investors choose to put their ...

Trikafta, made by Vertex Pharmaceuticals, is, as its name suggests, a combination of three drugs. It works for 90 percent of patients with cystic fibrosis, and will be priced at $311,000 per year.

The patients of cystic fibrosis (CF), their families, and public health experts are pinning their hopes on the expected outcome from the Karnataka High Court regarding availability of affordable ...

Vertex's approved cystic fibrosis drugs—Kalydeco, Orkambi, Symdeko, and Trikafta—will make the firm eligible to treat about 90% of the CF population, assuming international and pediatric ...

In the realm of gene-editing therapies, Vertex has launched Casgevy, an ex-vivo gene-edited cell therapy for the severe blood ...

But when she found out about the drug Trikafta, she started thinking, “we can manage this”. Cystic fibrosis is a condition that produces thick and sticky mucus and mainly affects the lungs and ...

A big part of why Prince-Saxon was even able to take on this feat is the drug Trikafta, which received public funding through Pharmac in April 2023 for people with CF aged six and over.

My evolving relationship with cystic fibrosis brings feelings of guilt and jealousy but also a deep sense of gratitude and understanding.

This would be in terms of the progress it made during the past year. It expanded the use of TRIKAFTA to target another huge batch of non-F508del CFTR mutations in Cystic Fibrosis [CF] patients ...

About 75% of patients in these key geographies have started treatment with one of Vertex's most effective medicines, Trikafta. That number stands at 33% in other countries. Vertex recently earned ...